Nitric Oxide Synthase: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 108: Line 108:
== Additional 3D Structures of Nitric Oxide Synthase ==
== Additional 3D Structures of Nitric Oxide Synthase ==


''Update June 2011''
''Updated December 2011''


'''Nitric Oxide Synthase''' (NOS) is an enzyme which catalyzes the production of the signaling molecule NO from arginine.  In mammals, NOS appears as 3 isozymes: neuronal NOS (nNOS), cytokine-inducible NOS (iNOS) and endothelial NOS (eNOS).  The N-terminal domain of NOS is an oxygenase domain (OD).  NOS cofactors are: NADPH, FAD, FMN, heme and O2. <br />
'''Nitric Oxide Synthase''' (NOS) is an enzyme which catalyzes the production of the signaling molecule NO from arginine.  In mammals, NOS appears as 3 isozymes: neuronal NOS (nNOS), cytokine-inducible NOS (iNOS) and endothelial NOS (eNOS).  The N-terminal domain of NOS is an oxygenase domain (OD).  NOS cofactors are: NADPH, FAD, FMN, heme and O2. <br />
Line 117: Line 117:
===Endothelial NOS===
===Endothelial NOS===


[[3nld]], [[3nle]], [[3nlf]], [[3nlg]], [[3jww]], [[3jwx]], [[3jwy]], [[3jwz]], [[3dqs]], [[3dqt]] – b-eNOS OD+pyrrolidinomethyl aminopyridine derivative – bovine<br />
[[3nld]], [[3nle]], [[3nlf]], [[3nlg]], [[3jww]], [[3jwx]], [[3jwy]], [[3jwz]], [[3dqs]], [[3dqt]], [[3pnh]] – b-eNOS OD+pyrrolidinomethyl pyridine derivative – bovine<br />
[[1dm6]] – b-eNOS OD+guanidine derivative<br />
[[1dm6]] – b-eNOS OD+guanidine derivative<br />
[[3nlh]] – b-eNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative<br />
[[3nlh]] – b-eNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative<br />
[[3e7s]] – b-eNOS OD+inhibitor<br />
[[1rs8]], [[1rs9]], [[1p6n]] – b-eNOS OD +dipeptide inhibitor<br />
[[1rs8]], [[1rs9]] – b-eNOS OD +dipeptide inhibitor<br />
[[1nse]] – b-eNOS OD<br />
[[1nse]] – b-eNOS OD<br />
[[1p6n]] – b-eNOS OD +dipeptide inhibitor<br />
[[1p6n]] – b-eNOS OD +dipeptide inhibitor<br />
Line 129: Line 128:
[[1i83]], [[1d1v]], [[1d1x]], [[1d1y]], [[1ed4]], [[9nse]] – b-eNOS OD+urea derivative<br />
[[1i83]], [[1d1v]], [[1d1x]], [[1d1y]], [[1ed4]], [[9nse]] – b-eNOS OD+urea derivative<br />
[[1dmj]], [[1dmk]] – b-eNOS OD+pterin derivative<br />
[[1dmj]], [[1dmk]] – b-eNOS OD+pterin derivative<br />
[[1foi]], [[1dmi]], [[1i83]], [[3n5p]], [[3n5q]], [[3n5r]], [[3n5s]], [[3n5t]], [[3n5v]], [[3n5w]], [[3n5x]], [[3n5y]], [[3n5z]], [[3n60]], [[3n61]], [[3n62]], [[3n63]], [[3n64]], [[3n65]], [[3n66]], [[3n67]], [[3n68]], [[3n69]], [[3n6a]], [[3n6b]], [[3n6c]], [[3n6d]], [[3n6e]], [[3n6f]], [[3n6g]], [[3nlt]], [[3nlu]] – b-eNOS OD+inhibitor<br />
[[1foi]], [[1dmi]], [[1i83]], [[3n5p]], [[3n5q]], [[3n5r]], [[3n5s]], [[3n5t]], [[3n5v]], [[3n5w]], [[3n5x]], [[3n5y]], [[3n5z]], [[3n60]], [[3n61]], [[3n62]], [[3n63]], [[3n64]], [[3n65]], [[3n66]], [[3n67]], [[3n68]], [[3n69]], [[3n6a]], [[3n6b]], [[3n6c]], [[3n6d]], [[3n6e]], [[3n6f]], [[3n6g]], [[3nlt]], [[3nlu]], [[3e7s]] – b-eNOS OD+inhibitor<br />
[[1d0c]], [[8nse]], [[1foj]], [[1ed5]] – b-eNOS OD+indazole derivative<br />
[[1d0c]], [[8nse]], [[1foj]], [[1ed5]], [[1d0o]], [[1d1w]] – b-eNOS OD+indazole derivative<br />
[[1dm8]] – b-eNOS OD+triazole derivative<br />
[[1dm8]] – b-eNOS OD+triazole derivative<br />
[[1ed6]] – b-eNOS OD+NO<br />
[[1ed6]] – b-eNOS OD+NO<br />
Line 139: Line 138:
[[1m9j]] – h-eNOS OD+chlorzoxazone<br />
[[1m9j]] – h-eNOS OD+chlorzoxazone<br />
[[1m9k]], [[1m9r]] – h-eNOS OD+indazole derivative<br />
[[1m9k]], [[1m9r]] – h-eNOS OD+indazole derivative<br />
[[1nsi]] - h-eNOS OD+ Zn


===Neuronal NOS===
===Neuronal NOS===
Line 146: Line 146:
[[3nli]], [[3nlj]], [[3nlk]], [[3nln]], [[3nlo]], [[3nlp]], [[3nlq]], [[3nlr]], [[3jws]], [[3jwt]], [[3jwu]], [[3jwv]], [[3jx0]], [[3jx1]], [[3jx2]], [[3jx3]], [[3jx4]], [[3jx5]], [[3jx6]], [[3dqr]] – r-nNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative – rat<br />
[[3nli]], [[3nlj]], [[3nlk]], [[3nln]], [[3nlo]], [[3nlp]], [[3nlq]], [[3nlr]], [[3jws]], [[3jwt]], [[3jwu]], [[3jwv]], [[3jx0]], [[3jx1]], [[3jx2]], [[3jx3]], [[3jx4]], [[3jx5]], [[3jx6]], [[3dqr]] – r-nNOS OD (mutant)+pyrrolidinomethyl aminopyridine derivative – rat<br />
[[3nlm]], [[3nny]], [[3nnz]], [[3n2r]], [[3b3o]], [[3b3p]], [[3b3m]], [[3b3n]] – r-nNOS OD+pyrrolidinomethyl aminopyridine derivative<br />
[[3nlm]], [[3nny]], [[3nnz]], [[3n2r]], [[3b3o]], [[3b3p]], [[3b3m]], [[3b3n]] – r-nNOS OD+pyrrolidinomethyl aminopyridine derivative<br />
[[3pne]], [[3pnf]], [[3png]], [[3svp]], [[3svq]] – r-nNOS OD+pyrrolidinomethyl methylpyridine derivative<br />
[[2hx3]] – r-nNOS OD+nitroguanidine derivative<br />
[[2hx3]] – r-nNOS OD+nitroguanidine derivative<br />
[[2hx4]], [[1zvl]] – r-nNOS OD+arginine derivative<br />
[[2hx4]], [[1zvl]] – r-nNOS OD+arginine derivative<br />
Line 153: Line 154:
[[1lzz]], [[1m00]] – r-nNOS OD+guanidine derivative<br />
[[1lzz]], [[1m00]] – r-nNOS OD+guanidine derivative<br />
[[3fc5]], [[1zvi]] – r-nNOS OD<br />
[[3fc5]], [[1zvi]] – r-nNOS OD<br />
[[1qau]] - r-nNOS OD PDZ domain<br />
[[1qav]] - r-nNOS OD PDZ domain + α-1 syntrophin<br />
[[1qw6]] – r-nNOS OD+arginine derivative<br />
[[1qw6]] – r-nNOS OD+arginine derivative<br />
[[1qwc]], [[3q99]], [[3q9a]] – r-nNOS OD+inhibitor<br />
[[1qwc]], [[3q99]], [[3q9a]] – r-nNOS OD+inhibitor<br />
Line 170: Line 173:
===Inducible NOS===
===Inducible NOS===
   
   
[[3nqs]], [[3e65]] – m-iNOS OD + pterin derivative<br />  
[[3nqs]], [[3e65]], [[3eai]], [[3ebd]], [[3ebf]], [[1r35]], [[2nod]]  – m-iNOS OD + pterin derivative<br />  
[[1jwj]], [[1jwk]] – m-iNOS OD (mutant)+ pterin derivative<br />
[[1jwj]], [[1jwk]] – m-iNOS OD (mutant)+ pterin derivative<br />
[[2bhj]] – m-iNOS OD+coumarin<br />
[[2bhj]] – m-iNOS OD+coumarin<br />
[[3eai]], [[3ebd]], [[3ebf]], [[1r35]], [[2nod]] – m-iNOS OD+pterin derivative<br />
[[3nod]] – m-iNOS OD+product analog<br />
[[3nod]] – m-iNOS OD+product analog<br />
[[1noc]] – m-iNOS OD+chloramphenicol acetyltransferase<br />
[[1noc]] – m-iNOS OD+chloramphenicol acetyltransferase<br />
[[3e67]] – m-iNOS OD+4-MAP<br />
[[3e67]] – m-iNOS OD+4-MAP<br />
[[3e68]], [[3e6l]], [[3e6n]], [[3e6o]], [[3e6t]], [[3e7i]], [[3e7m]], [[3e7t]], [[1vaf]], [[1qw5]], [[1dd7]], [[2y37]] – m-iNOS OD+inhibitor <br />
[[3e68]], [[3e6l]], [[3e6n]], [[3e6o]], [[3e6t]], [[3e7i]], [[3e7m]], [[3e7t]], [[1vaf]], [[1qw5]], [[1dd7]], [[2y37]] – m-iNOS OD+inhibitor <br />
[[2orq]], [[2orr]], [[2ors]], [[2ort]], [[2oro]], [[2orp]], [[1nos]] – m-iNOS OD+imidazole derivative<br />
[[2orq]], [[2orr]], [[2ors]], [[2ort]], [[2oro]], [[2orp]], [[1nos]], [[3nw2]] – m-iNOS OD+imidazole derivative<br />
[[1df1]] - m-iNOS OD+ urea derivative<br />
[[3dwj]] – m-iNOS OD (mutant)<br />
[[3dwj]] – m-iNOS OD (mutant)<br />
[[1qom]] - m-iNOS OD<br />
[[1qw4]], [[1dwv]], [[1dww]], [[1dwx]], [[1nod]] – m-iNOS OD+arginine derivative<br />
[[1qw4]], [[1dwv]], [[1dww]], [[1dwx]], [[1nod]] – m-iNOS OD+arginine derivative<br />
[[2nos]] – m-iNOS OD+guanidine derivative<br />
[[2nos]] – m-iNOS OD+guanidine derivative<br />